GEP20002176B - Ointment “Bentastatin” for Treatment of Fungus Diseases of Skin and Mucous Membrane and Inflammatory Processes - Google Patents
Ointment “Bentastatin” for Treatment of Fungus Diseases of Skin and Mucous Membrane and Inflammatory ProcessesInfo
- Publication number
- GEP20002176B GEP20002176B GEAP19994755A GEAP1999004755A GEP20002176B GE P20002176 B GEP20002176 B GE P20002176B GE AP19994755 A GEAP19994755 A GE AP19994755A GE AP1999004755 A GEAP1999004755 A GE AP1999004755A GE P20002176 B GEP20002176 B GE P20002176B
- Authority
- GE
- Georgia
- Prior art keywords
- treatment
- ointment
- inflammatory processes
- skin
- bentastatin
- Prior art date
Links
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 239000002674 ointment Substances 0.000 title abstract 2
- 208000031888 Mycoses Diseases 0.000 title 1
- 210000004400 mucous membrane Anatomy 0.000 title 1
- 240000000950 Hippophae rhamnoides Species 0.000 abstract 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract 1
- 239000004927 clay Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960000988 nystatin Drugs 0.000 abstract 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Technical Result Widening of the medicinal means assortment for treatment of skin diseases and inflammatory processes, increase in treatment efficiency. 2. Essence An ointment contains nystatin, sea buckthorn oil and hydrophilic gel of clay - askane. 3. Field of Application Medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GEAP19994755A GEP20002176B (en) | 1999-04-15 | 1999-04-15 | Ointment “Bentastatin” for Treatment of Fungus Diseases of Skin and Mucous Membrane and Inflammatory Processes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GEAP19994755A GEP20002176B (en) | 1999-04-15 | 1999-04-15 | Ointment “Bentastatin” for Treatment of Fungus Diseases of Skin and Mucous Membrane and Inflammatory Processes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP20002176B true GEP20002176B (en) | 2000-07-25 |
Family
ID=82786215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP19994755A GEP20002176B (en) | 1999-04-15 | 1999-04-15 | Ointment “Bentastatin” for Treatment of Fungus Diseases of Skin and Mucous Membrane and Inflammatory Processes |
Country Status (1)
| Country | Link |
|---|---|
| GE (1) | GEP20002176B (en) |
-
1999
- 1999-04-15 GE GEAP19994755A patent/GEP20002176B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI956014A0 (en) | Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS | |
| WO2005000161A3 (en) | Methods and devices for occluding body lumens and/or for delivering therapeutic agents | |
| EP0693281A3 (en) | Pharmaceutical formulations containing fluoxetine | |
| ATE125445T1 (en) | ORAL COMPOSITION FOR THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES. | |
| AU6628496A (en) | Polyether block copolymer micellar compositions for targeting biological agents | |
| AU1865100A (en) | Hyaluronate lyase used for promoting penetration in topical agents | |
| TR200103819T2 (en) | ET743 compositions and uses in cancer treatment | |
| GR3032512T3 (en) | Sexual steroid-containing transdermal therapeutic systems | |
| DK1345595T3 (en) | Ion strength-independent pharmaceutical formulation with depot release | |
| TR199900661T2 (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin infections | |
| BG101126A (en) | The use of muramylpeptide compounds | |
| NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
| WO2000016786A3 (en) | Oxihumic acid and its use in the treatment of various conditions | |
| CA2319542A1 (en) | The treatment of sexual dysfunction in certain patient groups | |
| AU2001267561A1 (en) | Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents | |
| MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
| PL326629A1 (en) | Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system | |
| GEP20002177B (en) | Ointment “Levaskani” for Treatment of Wounds and Burns | |
| GEP20012377B (en) | Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases | |
| SE9700617D0 (en) | New composition | |
| GEU2000587Y (en) | Medicinal Ointment Turmanidze-Burduli Derma | |
| EP1027894A3 (en) | Pharmaceutical preparation for the treatment of inflammatory processes | |
| PT1347753E (en) | Topical composition and method for the treatment of urinary incontinence of STRESS | |
| GEP20043316B (en) | Ointment for Treatment of Purulent Diseases, Wounds and Parodontosis | |
| GEP20033135B (en) | Means for Treatment of Fungoid Diseases |